Do I need an in-person exam for Ozempic in California?

If you’ve been researching GLP-1 medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I actually get these medications through telehealth? The short answer is yes — in most cases, you can legally obtain these prescriptions via online healthcare services. But the details vary significantly by state, and understanding the current rules can save you time, money, and frustration.

This comprehensive guide breaks down everything you need to know about accessing weight loss medications through telehealth in 2025, including federal regulations, state-specific requirements, provider qualifications, and what to expect during your virtual consultation.

Understanding the Federal Landscape: Why Telehealth Works for Weight Loss Medications

The key fact: GLP-1 medications like Wegovy (semaglutide 2.4mg), Ozempic (semaglutide 0.5-1mg), and Mounjaro/Zepbound (tirzepatide) are not controlled substances under federal law. This distinction is crucial because it means the Ryan Haight Act — which normally requires an in-person examination before prescribing controlled medications via telehealth — doesn’t apply to these weight loss drugs.

During the COVID-19 pandemic, federal telehealth rules were dramatically relaxed. While those temporary flexibilities primarily affected controlled substances (like Adderall or buprenorphine), they accelerated the overall adoption of telemedicine across all healthcare areas, including obesity treatment. As of December 2025, the DEA has extended telehealth prescribing flexibilities for controlled substances through December 31, 2025, while non-controlled medications like GLP-1 agonists continue to be fully accessible via telemedicine under standard federal guidelines.

What this means for you: Under federal law, a licensed healthcare provider can evaluate you via video consultation and electronically send a prescription for weight loss medication to your pharmacy — no in-person visit required at the federal level. However, individual states can (and do) impose additional requirements.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

State Requirements: Where You Can Get Weight Loss Medications Via Telehealth

While federal law permits telehealth prescribing of these medications, state medical boards set their own standards. Some states have embraced telehealth fully, while others require initial in-person examinations or periodic follow-ups. Here’s what you need to know about key states:

States with Minimal Telehealth Restrictions

California, Washington, New York, Illinois, Pennsylvania, and Connecticut have adopted progressive telehealth policies that allow providers to prescribe weight loss medications entirely through virtual consultations. In these states:

• No initial in-person examination is legally required
• Video consultations can establish a valid patient-provider relationship
• Electronic prescribing is standard (and often mandatory)
• Follow-up appointments can be conducted remotely

For example, Washington state has been a telehealth pioneer with comprehensive privacy protections under the My Health My Data Act (2023), which is particularly important given the sensitive nature of weight-loss treatment data. California allows nurse practitioners to practice independently after gaining experience, expanding access to telehealth weight loss services across the state.

States Requiring Initial In-Person Examinations

Several states mandate at least one in-person visit before or shortly after starting telehealth treatment for weight loss medications:

Arkansas, Georgia, Delaware, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, and Virginia all have policies requiring an initial physical examination. However, the specifics vary:

• Arkansas has some of the strictest telemedicine rules in the country, requiring the first examination to be conducted in person before any telehealth prescribing can occur
• Texas generally expects an initial in-person exam, though telehealth providers can often coordinate this with local clinics to meet the requirement while maintaining the convenience of remote care
• New Jersey and Virginia require comprehensive initial evaluations including physical exams, laboratory work, and documented diet/exercise plans before prescribing obesity medications

Georgia recently expanded prescribing authority (effective July 2024), allowing nurse practitioners and physician assistants to prescribe Schedule II controlled substances with physician delegation — though this doesn’t eliminate the initial in-person requirement for weight loss treatment.

States with Additional Treatment Requirements

Beyond in-person visit requirements, some states impose specific treatment protocols:

Florida requires patients to:

• Have a BMI of 30 or higher (or 27+ with comorbidities)
• Attend follow-up visits at least once every 3 months during treatment
• Receive documented counseling on diet and exercise

Connecticut mandates that obesity treatment include behavioral counseling alongside medication, ensuring a comprehensive approach to weight management.

Virginia requires a follow-up appointment within 30 days of starting therapy to assess tolerance and effectiveness, with ongoing monitoring throughout treatment.

Who Can Prescribe Weight Loss Medications via Telehealth?

Understanding provider qualifications is essential when choosing a telehealth service. Here’s how different types of providers can prescribe GLP-1 medications:

Medical Doctors (MD) and Doctors of Osteopathy (DO)

All states allow physicians licensed in that state to prescribe weight loss medications via telehealth. Your telehealth provider must hold an active medical license in the state where you’re physically located during the consultation.

Nurse Practitioners (NPs)

Nurse practitioner authority varies significantly by state:

Full Practice Authority States (34 states plus DC as of 2025): NPs can evaluate patients, diagnose conditions, and prescribe medications independently without physician oversight. These states include:

• California (after 3+ years of supervised practice)
• New York (after 3,600 hours of experience)
• Washington, Arizona, Oregon, Nevada
• Connecticut, Delaware, Maryland
• And many others

Reduced Practice Authority States: NPs can prescribe but require a collaborative agreement or supervisory relationship with a physician. Examples include:

• Texas (requires formal physician agreement; cannot prescribe certain controlled substances)
• Florida (limited independence in primary care settings)
• Georgia (requires physician protocols, though authority expanded in 2024)

Restricted Practice States (only 4 remaining): NPs face significant limitations on prescribing. However, even in these states, NPs can typically prescribe non-controlled medications like GLP-1s with appropriate physician oversight.

Physician Assistants (PAs)

PAs can prescribe weight loss medications in all states, though they generally require some level of physician supervision or collaboration. The degree of autonomy varies, but most states allow PAs to prescribe non-controlled substances with a supervising physician agreement.

Why this matters: Many telehealth platforms like Klarity Health utilize nurse practitioners and physician assistants to increase provider availability and reduce wait times. As long as these providers operate within their state’s scope of practice and maintain appropriate oversight where required, patients can feel confident in the quality and legality of their care.

What to Expect During a Telehealth Weight Loss Consultation

Reputable telehealth services follow rigorous evaluation protocols to ensure patient safety and regulatory compliance. Here’s what a typical consultation involves:

Pre-Consultation Screening

Before your video appointment, you’ll complete:

• Comprehensive medical history questionnaire: Including current medications, allergies, previous weight loss attempts, and relevant medical conditions
• Height and weight documentation: Some services require photo verification or coordination with local labs for accurate measurements
• Health screening questions: To identify contraindications like personal/family history of medullary thyroid carcinoma, MEN2 syndrome, pregnancy plans, pancreatitis, or severe GI disorders

The Video Consultation

During your appointment (typically 15-30 minutes), your provider will:

• Review your medical history and weight loss goals
• Calculate and discuss your BMI (Body Mass Index)
• Explain how GLP-1 medications work and set realistic expectations
• Discuss potential side effects (nausea, GI upset, injection site reactions)
• Review contraindications and safety precautions
• Explain the importance of lifestyle modifications alongside medication
• Answer your questions about treatment duration, cost, and insurance coverage

Clinical Criteria for Prescription

Legitimate providers follow FDA-approved guidelines and will only prescribe if you meet clinical criteria:

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 with weight-related comorbidities such as:
• Type 2 diabetes
• High blood pressure
• High cholesterol
• Sleep apnea
• Cardiovascular disease risk factors

Providers should also verify you’ve attempted lifestyle modifications (diet and exercise) unless medically contraindicated.

Treatment Plan and Follow-Up

If approved, your provider will:

• Create a personalized treatment plan including medication dosing schedule
• Provide injection training resources (these are self-administered medications)
• Send your prescription electronically to your preferred pharmacy
• Schedule follow-up appointments (typically at 1 month, then every 2-3 months)
• Monitor your progress, adjust dosing, and assess for side effects

States with mandatory follow-up requirements (like Florida’s 3-month rule or Virginia’s 30-day check-in) will ensure compliance through scheduled appointments.

Red Flags: How to Avoid Illegitimate Telehealth Services

The popularity of medications like Wegovy and Ozempic has unfortunately attracted some questionable operators. Protect yourself by watching for these warning signs:

Guaranteed Prescriptions Without Evaluation

Any service that promises you’ll definitely get a prescription before assessing your medical history is operating outside proper medical standards. Legitimate providers evaluate each patient individually and may determine the medication isn’t appropriate.

Compounded or ‘Generic’ Semaglutide Offers

Critical update: The FDA ended the emergency compounding allowance for semaglutide in May 2025, effectively banning retail compounding of these medications except in extremely limited circumstances. Any telehealth service offering ‘compounded Wegovy’ or similar products is likely violating FDA regulations. Stick with FDA-approved, brand-name medications dispensed through licensed pharmacies.

No Licensed Provider Information

Reputable services clearly identify their providers, including:

• Full names and credentials (MD, DO, NP, PA)
• State license numbers
• Where they’re licensed to practice

If you can’t easily find this information or the service is vague about who will see you, that’s a major red flag.

Minimal or No Follow-Up

Weight loss medications require ongoing monitoring for safety and effectiveness. Services that don’t schedule regular follow-ups or fail to track your progress aren’t providing appropriate medical care.

Pressure to Buy ‘Packages’ or ‘Bundles’

While treatment programs often involve multi-month commitments, be wary of services that pressure you into long-term purchases before you’ve even tried the medication or demand large upfront payments.

How Klarity Health Approaches Weight Loss Treatment

At Klarity Health, we’ve designed our weight loss program to balance accessibility with clinical excellence and full regulatory compliance:

Provider Availability: We maintain a network of licensed healthcare providers across multiple states, ensuring you can connect with a qualified MD, DO, or NP who is properly licensed in your location. Our providers have specific training in obesity medicine and telehealth best practices.

Transparent Pricing: We accept both insurance and cash pay, with clear, upfront pricing. There are no hidden fees, and we help you understand your coverage options before your first appointment. Many patients find our cash-pay rates more affordable than their insurance copays for these medications.

State-Specific Compliance: Our platform automatically ensures compliance with your state’s requirements. If you’re in a state requiring an initial in-person exam, we’ll help coordinate that. If your state allows fully virtual care, we make it seamless.

Comprehensive Care Approach: Your Klarity provider won’t just write a prescription. We’ll help you develop a complete weight management plan including:

• Nutritional guidance
• Exercise recommendations
• Behavioral strategies
• Regular monitoring and dose adjustments
• Support throughout your journey

Safety First: We carefully screen for contraindications, provide detailed education about side effects, and maintain ongoing oversight of your treatment. If we determine a GLP-1 medication isn’t right for you, we’ll discuss alternative approaches.

Understanding the Medications: Wegovy, Ozempic, and Mounjaro

Let’s clarify what these medications are and how they’re used:

Wegovy (Semaglutide 2.4mg)

• FDA Status: Approved specifically for chronic weight management (June 2021)
• Clinical Use: For adults with BMI ≥30 or ≥27 with comorbidities
• Administration: Once-weekly self-injection
• Typical Results: 15-20% body weight loss over 68 weeks when combined with lifestyle changes
• Insurance Coverage: Increasingly covered by major insurers, though prior authorization often required

Ozempic (Semaglutide 0.5-1mg)

• FDA Status: Approved for Type 2 diabetes; used off-label for weight loss
• Important Note: Same active ingredient as Wegovy but at lower doses originally intended for diabetes management
• When Prescribed: Often when insurance won’t cover Wegovy, or for patients with both diabetes and obesity
• Provider Requirement: Must document off-label use rationale and obtain informed consent

Mounjaro/Zepbound (Tirzepatide)

• FDA Status: Mounjaro approved for diabetes; Zepbound (higher-dose tirzepatide) approved for obesity in late 2023
• Mechanism: Dual GIP/GLP-1 receptor agonist (slightly different from semaglutide)
• Typical Results: Studies show 20-25% body weight loss — potentially more effective than semaglutide for some patients
• Administration: Once-weekly self-injection with dose titration packs

All three medications are:

• Non-controlled substances (no DEA scheduling)
• Injectable (pre-filled pens for self-administration)
• Long-term treatments (not quick-fix ‘diet pills’)
• Most effective when combined with lifestyle modifications

Common Patient Questions About Telehealth Weight Loss Treatment

Q: How quickly can I get started?A: With services like Klarity Health, you can often book an appointment within 24-48 hours. If approved, your prescription can be sent to the pharmacy the same day. However, in states requiring initial in-person exams, there may be additional coordination time.

Q: Will my insurance cover telehealth weight loss medications?A: Coverage varies significantly by plan. Many commercial insurers now cover Wegovy and Zepbound with prior authorization, though Medicare doesn’t currently cover weight loss medications. Klarity can help verify your benefits before your appointment and offer transparent cash-pay pricing if needed.

Q: Can I switch from my current provider to telehealth?A: Yes. If you’re already on a GLP-1 medication and want to transition to telehealth management, Klarity providers can review your current treatment and continue your care (assuming they’re licensed in your state and you meet ongoing treatment criteria).

Q: What if I experience side effects?A: Common side effects like nausea, constipation, or fatigue are usually manageable with dose adjustments and dietary modifications. Your Klarity provider is available for guidance, and in most cases, we can schedule a same-day or next-day appointment to address concerns.

Q: How long will I need to take the medication?A: These are chronic weight management medications, similar to blood pressure or cholesterol drugs. Many patients continue treatment long-term to maintain their weight loss. Your provider will regularly assess whether ongoing treatment is appropriate and effective for you.

Q: Can I get these medications if I just want to lose 10-15 pounds?A: These medications are FDA-approved for clinical obesity or overweight with comorbidities — not for cosmetic weight loss. Legitimate telehealth providers will decline to prescribe if you don’t meet medical criteria, and will instead recommend evidence-based lifestyle approaches.

The Future of Telehealth Weight Loss Treatment

The regulatory landscape continues to evolve in favor of expanded telehealth access:

Federal Developments: The DEA is expected to issue permanent telehealth prescribing regulations in 2026, though these primarily affect controlled substances. Pending federal legislation like the TREATS Act could further solidify telehealth flexibilities across all medical areas.

State Trends: More states are moving toward full practice authority for nurse practitioners and streamlined telehealth requirements. In 2025 alone, Mississippi, Pennsylvania, and other states have bills pending to expand provider autonomy and reduce barriers to remote care.

Technology Integration: Interstate licensure compacts for both physicians and nurse practitioners are making it easier for telehealth platforms to serve patients across multiple states without cumbersome individual licensing processes.

Clinical Acceptance: As telehealth weight loss programs demonstrate safety and effectiveness comparable to in-person care, medical boards are increasingly comfortable with remote obesity treatment when proper standards are maintained.

What this means for patients: Access to weight loss medications via telehealth will likely become easier and more standardized across states over the next few years, with continued emphasis on quality care and patient safety.

Your Next Steps: Getting Started with Telehealth Weight Loss Treatment

If you’re considering GLP-1 medications for weight management, here’s how to move forward:

1. Check Your State’s Requirements: Review the state-specific table in this article to understand what’s required where you live.

2. Verify Medical Eligibility: Calculate your BMI and consider whether you have weight-related health conditions. Be honest about your medical history and goals.

3. Choose a Reputable Provider: Look for telehealth services that:

• Employ licensed, credentialed providers in your state
• Offer transparent pricing and insurance options
• Provide comprehensive treatment plans (not just prescriptions)
• Schedule regular follow-up appointments
• Have clear protocols for managing side effects

1. Gather Your Information: Before your consultation, compile:

• Current medication list
• Relevant medical records
• Recent weight measurements
• Questions for your provider

1. Book Your Consultation: Services like Klarity Health make scheduling easy, with appointments often available within 24-48 hours.

2. Commit to the Process: Remember that medication is just one tool in weight management. Success requires engagement with the full treatment plan, including nutrition, physical activity, and behavioral changes.

Take Control of Your Weight Loss Journey

Telehealth has revolutionized access to evidence-based obesity treatment, making effective medications like Wegovy, Ozempic, and Mounjaro available to millions of Americans who might not otherwise have access to specialized care. While state regulations vary, the overall trend is toward increased accessibility with appropriate medical oversight.

At Klarity Health, we’re committed to providing safe, effective, and affordable weight loss treatment through telehealth. Our experienced providers are ready to evaluate your individual situation, discuss your options, and support you throughout your weight management journey — all from the convenience of your home.

Ready to explore whether GLP-1 medications are right for you? Schedule a consultation with Klarity Health today. Our providers are available in multiple states, we accept insurance and offer transparent cash pricing, and we’ll ensure full compliance with your state’s requirements while delivering the personalized care you deserve.

Your healthier future starts with a simple video call. Let us help you take that first step.

Research Sources and References

This article is based on current regulations and clinical guidelines as of December 2025. The following authoritative sources were consulted:

1. DEA and HHS Extend Telemedicine Flexibilities through 2025 – U.S. Drug Enforcement Administration, November 15, 2024. Official announcement confirming extension of telehealth prescribing flexibilities for controlled substances through December 31, 2025.

2. COVID-era telehealth prescribing extended: Adderall and other controlled medications – Axios News, November 18, 2024. News coverage of the third DEA extension, providing context on the impact for patients and providers.

3. DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025 – McDermott Will & Emery LLP, November 18, 2024. Expert legal analysis of federal telehealth regulations, including discussion of the Ryan Haight Act’s application to non-controlled medications.

4. Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs – Goodwin Procter LLP, March 27, 2024. Comprehensive review of state-specific requirements for prescribing obesity medications, including detailed information on Florida, New Jersey, and Virginia regulations.

5. FDA Ends Emergency Compounding of Semaglutide; Impact on Telehealth Companies – Reuters, May 30, 2025. Coverage of FDA’s decision to ban routine compounding of weight-loss medications and its effects on the telehealth industry.

Verified as of: December 17, 2025

Note: Healthcare regulations evolve frequently. While this information was accurate at publication, readers should verify current requirements in their state. Consult with a licensed healthcare provider for personalized medical advice.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid